ID IKZF4_HUMAN Reviewed; 585 AA. AC Q9H2S9; Q96JP3; DT 11-SEP-2007, integrated into UniProtKB/Swiss-Prot. DT 11-SEP-2007, sequence version 2. DT 10-FEB-2021, entry version 158. DE RecName: Full=Zinc finger protein Eos; DE AltName: Full=Ikaros family zinc finger protein 4; GN Name=IKZF4; Synonyms=KIAA1782, ZNFN1A4; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Brain; RX PubMed=11347906; DOI=10.1093/dnares/8.2.85; RA Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. XX. The RT complete sequences of 100 new cDNA clones from brain which code for large RT proteins in vitro."; RL DNA Res. 8:85-95(2001). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 53-585 (ISOFORM 1), FUNCTION, TISSUE RP SPECIFICITY, AND INTERACTION WITH IKZF1; IKZF2; IKZF3 AND IKZF5. RX PubMed=10978333; DOI=10.1074/jbc.m005457200; RA Perdomo J., Holmes M., Chong B., Crossley M.; RT "Eos and pegasus, two members of the Ikaros family of proteins with RT distinct DNA binding activities."; RL J. Biol. Chem. 275:38347-38354(2000). RN [4] RP FUNCTION. RX PubMed=12015313; DOI=10.1074/jbc.m201694200; RA Koipally J., Georgopoulos K.; RT "A molecular dissection of the repression circuitry of Ikaros."; RL J. Biol. Chem. 277:27697-27705(2002). RN [5] RP FUNCTION, INTERACTION WITH CTBP2, SUBCELLULAR LOCATION, AND MUTAGENESIS OF RP 425-PRO--ASP-427. RX PubMed=12444977; DOI=10.1046/j.1432-1033.2002.03313.x; RA Perdomo J., Crossley M.; RT "The Ikaros family protein Eos associates with C-terminal-binding protein RT corepressors."; RL Eur. J. Biochem. 269:5885-5892(2002). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [7] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-100 AND LYS-500, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=28112733; DOI=10.1038/nsmb.3366; RA Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C., RA Nielsen M.L.; RT "Site-specific mapping of the human SUMO proteome reveals co-modification RT with phosphorylation."; RL Nat. Struct. Mol. Biol. 24:325-336(2017). RN [8] RP STRUCTURE BY NMR OF 155-216 IN COMPLEX WITH ZINC IONS. RG Northeast structural genomics consortium (NESG); RT "Solution NMR structure of zinc finger protein EOS from Homo sapiens, RT Northeast structural genomics consortium (NESG) target HR7992A."; RL Submitted (SEP-2013) to the PDB data bank. CC -!- FUNCTION: DNA-binding protein that binds to the 5'GGGAATRCC-3' Ikaros- CC binding sequence. Transcriptional repressor. Interacts with SPI1 and CC MITF to repress transcription of the CTSK and ACP5 promoters via CC recruitment of corepressors SIN3A and CTBP2. May be involved in the CC development of central and peripheral nervous systems. Essential for CC the inhibitory function of regulatory T-cells (Treg). Mediates FOXP3- CC mediated gene silencing in regulatory T-cells (Treg) via recruitment of CC corepressor CTBP1 (By similarity). {ECO:0000250|UniProtKB:Q8C208, CC ECO:0000269|PubMed:10978333, ECO:0000269|PubMed:12015313, CC ECO:0000269|PubMed:12444977}. CC -!- SUBUNIT: Self-associates. Interacts with other family members; IKZF1, CC IKZF2, IKZF3 and IKZF5. Interacts with CTBP2. Interacts with SPI1, CC MITF, FOXP3 and CTBP1 (By similarity). {ECO:0000250|UniProtKB:Q8C208, CC ECO:0000269|PubMed:12444977}. CC -!- INTERACTION: CC Q9H2S9; O00311: CDC7; NbExp=3; IntAct=EBI-1640423, EBI-374980; CC Q9H2S9; P48730: CSNK1D; NbExp=3; IntAct=EBI-1640423, EBI-751621; CC Q9H2S9; Q96EZ8: MCRS1; NbExp=3; IntAct=EBI-1640423, EBI-348259; CC Q9H2S9; Q9H8S9: MOB1A; NbExp=3; IntAct=EBI-1640423, EBI-748229; CC Q9H2S9; Q70IA8: MOB3C; NbExp=3; IntAct=EBI-1640423, EBI-9679267; CC Q9H2S9; Q9Y4C2-2: TCAF1; NbExp=3; IntAct=EBI-1640423, EBI-11974855; CC Q9H2S9; Q15560: TCEA2; NbExp=3; IntAct=EBI-1640423, EBI-710310; CC Q9H2S9; P42681: TXK; NbExp=3; IntAct=EBI-1640423, EBI-7877438; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12444977}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9H2S9-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9H2S9-2; Sequence=VSP_027688; CC -!- TISSUE SPECIFICITY: Highly expressed in skeletal muscle, low levels of CC expression in heart, thymus, kidney, liver, and spleen. Expressed in CC the hematopoietic cell lines MOLT-4, NALM-6 and K-562. Highly expressed CC in THP-1 and M-07e cell lines, which have characteristics of myeloid CC and early megakaryocytic cells respectively. CC {ECO:0000269|PubMed:10978333}. CC -!- DOMAIN: The N-terminal zinc fingers are involved in sequence-specific CC DNA binding and heterotypic associations with other family members. CC -!- DOMAIN: C-terminal zinc fingers mediate homodimerization. CC -!- MISCELLANEOUS: 'Eos' means 'rising sun' in Greek. CC -!- SIMILARITY: Belongs to the Ikaros C2H2-type zinc-finger protein family. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAG39221.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=BAB47411.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AB058685; BAB47411.1; ALT_INIT; mRNA. DR EMBL; BX647761; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; AF230809; AAG39221.1; ALT_INIT; mRNA. DR CCDS; CCDS44917.1; -. [Q9H2S9-1] DR RefSeq; NP_071910.3; NM_022465.3. [Q9H2S9-1] DR RefSeq; XP_016875294.1; XM_017019805.1. DR RefSeq; XP_016875295.1; XM_017019806.1. [Q9H2S9-1] DR RefSeq; XP_016875296.1; XM_017019807.1. [Q9H2S9-1] DR RefSeq; XP_016875297.1; XM_017019808.1. [Q9H2S9-1] DR RefSeq; XP_016875298.1; XM_017019809.1. [Q9H2S9-1] DR RefSeq; XP_016875299.1; XM_017019810.1. [Q9H2S9-1] DR RefSeq; XP_016875300.1; XM_017019811.1. [Q9H2S9-1] DR PDB; 2MA7; NMR; -; A=155-216. DR PDBsum; 2MA7; -. DR SMR; Q9H2S9; -. DR BioGRID; 122146; 24. DR CORUM; Q9H2S9; -. DR ELM; Q9H2S9; -. DR IntAct; Q9H2S9; 13. DR STRING; 9606.ENSP00000262032; -. DR iPTMnet; Q9H2S9; -. DR PhosphoSitePlus; Q9H2S9; -. DR BioMuta; IKZF4; -. DR DMDM; 158564025; -. DR jPOST; Q9H2S9; -. DR MassIVE; Q9H2S9; -. DR MaxQB; Q9H2S9; -. DR PaxDb; Q9H2S9; -. DR PeptideAtlas; Q9H2S9; -. DR PRIDE; Q9H2S9; -. DR ProteomicsDB; 80588; -. [Q9H2S9-1] DR ProteomicsDB; 80589; -. [Q9H2S9-2] DR Antibodypedia; 27854; 174 antibodies. DR DNASU; 64375; -. DR Ensembl; ENST00000262032; ENSP00000262032; ENSG00000123411. [Q9H2S9-1] DR Ensembl; ENST00000431367; ENSP00000412101; ENSG00000123411. [Q9H2S9-1] DR Ensembl; ENST00000547167; ENSP00000448419; ENSG00000123411. [Q9H2S9-1] DR GeneID; 64375; -. DR KEGG; hsa:64375; -. DR UCSC; uc001sjb.1; human. [Q9H2S9-1] DR CTD; 64375; -. DR DisGeNET; 64375; -. DR GeneCards; IKZF4; -. DR HGNC; HGNC:13179; IKZF4. DR HPA; ENSG00000123411; Low tissue specificity. DR MIM; 606239; gene. DR neXtProt; NX_Q9H2S9; -. DR OpenTargets; ENSG00000123411; -. DR PharmGKB; PA162391948; -. DR VEuPathDB; HostDB:ENSG00000123411.14; -. DR eggNOG; KOG1721; Eukaryota. DR GeneTree; ENSGT00940000158308; -. DR HOGENOM; CLU_025502_0_0_1; -. DR InParanoid; Q9H2S9; -. DR OMA; MHPVDLD; -. DR OrthoDB; 385551at2759; -. DR PhylomeDB; Q9H2S9; -. DR TreeFam; TF331189; -. DR PathwayCommons; Q9H2S9; -. DR SIGNOR; Q9H2S9; -. DR BioGRID-ORCS; 64375; 9 hits in 895 CRISPR screens. DR ChiTaRS; IKZF4; human. DR GeneWiki; IKZF4; -. DR GenomeRNAi; 64375; -. DR Pharos; Q9H2S9; Tbio. DR PRO; PR:Q9H2S9; -. DR Proteomes; UP000005640; Chromosome 12. DR RNAct; Q9H2S9; protein. DR Bgee; ENSG00000123411; Expressed in right adrenal gland and 200 other tissues. DR ExpressionAtlas; Q9H2S9; baseline and differential. DR Genevisible; Q9H2S9; HS. DR GO; GO:0016604; C:nuclear body; IDA:HPA. DR GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0005634; C:nucleus; TAS:UniProtKB. DR GO; GO:0032991; C:protein-containing complex; IMP:CAFA. DR GO; GO:0043425; F:bHLH transcription factor binding; IEA:Ensembl. DR GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central. DR GO; GO:0019904; F:protein domain specific binding; IPI:CAFA. DR GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central. DR GO; GO:0008270; F:zinc ion binding; IMP:CAFA. DR GO; GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl. DR GO; GO:0051260; P:protein homooligomerization; IMP:CAFA. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central. DR InterPro; IPR036236; Znf_C2H2_sf. DR InterPro; IPR013087; Znf_C2H2_type. DR Pfam; PF00096; zf-C2H2; 3. DR SMART; SM00355; ZnF_C2H2; 6. DR SUPFAM; SSF57667; SSF57667; 3. DR PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5. DR PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Alternative splicing; DNA-binding; KW Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein; KW Reference proteome; Repeat; Repressor; Transcription; KW Transcription regulation; Ubl conjugation; Zinc; Zinc-finger. FT CHAIN 1..585 FT /note="Zinc finger protein Eos" FT /id="PRO_0000299468" FT ZN_FING 159..181 FT /note="C2H2-type 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 187..209 FT /note="C2H2-type 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 215..237 FT /note="C2H2-type 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 248..271 FT /note="C2H2-type 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 530..552 FT /note="C2H2-type 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT ZN_FING 558..582 FT /note="C2H2-type 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00042" FT REGION 281..585 FT /note="Interaction with FOXP3" FT /evidence="ECO:0000250|UniProtKB:Q8C208" FT MOTIF 425..429 FT /note="CTBP-binding motif PEDLA" FT MOD_RES 105 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9UKS7" FT MOD_RES 335 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:Q9UKS7" FT CROSSLNK 100 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000244|PubMed:28112733" FT CROSSLNK 500 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000244|PubMed:28112733" FT VAR_SEQ 1..61 FT /note="MHTPPALPRRFQGGGRVRTPGSHRQGKDNLERDPSGGCVPDFLPQAQDSNHF FT IMESLFCES -> MDSRYLQLQLYLPSCSLLQG (in isoform 2)" FT /evidence="ECO:0000303|PubMed:11347906" FT /id="VSP_027688" FT MUTAGEN 425..427 FT /note="PED->AAA: No effect on CTBP2 interaction." FT /evidence="ECO:0000269|PubMed:12444977" FT CONFLICT 145 FT /note="E -> K (in Ref. 3; AAG39221)" FT /evidence="ECO:0000305" FT CONFLICT 310 FT /note="P -> A (in Ref. 3; AAG39221)" FT /evidence="ECO:0000305" FT CONFLICT 361 FT /note="A -> G (in Ref. 3; AAG39221)" FT /evidence="ECO:0000305" FT CONFLICT 390 FT /note="N -> H (in Ref. 3; AAG39221)" FT /evidence="ECO:0000305" FT CONFLICT 524 FT /note="G -> S (in Ref. 3; AAG39221)" FT /evidence="ECO:0000305" FT HELIX 173..181 FT /evidence="ECO:0000244|PDB:2MA7" FT STRAND 187..189 FT /evidence="ECO:0000244|PDB:2MA7" FT TURN 190..193 FT /evidence="ECO:0000244|PDB:2MA7" FT STRAND 194..197 FT /evidence="ECO:0000244|PDB:2MA7" FT HELIX 199..205 FT /evidence="ECO:0000244|PDB:2MA7" FT TURN 206..209 FT /evidence="ECO:0000244|PDB:2MA7" SQ SEQUENCE 585 AA; 64106 MW; 42AE169A3E2E14D3 CRC64; MHTPPALPRR FQGGGRVRTP GSHRQGKDNL ERDPSGGCVP DFLPQAQDSN HFIMESLFCE SSGDSSLEKE FLGAPVGPSV STPNSQHSSP SRSLSANSIK VEMYSDEESS RLLGPDERLL EKDDSVIVED SLSEPLGYCD GSGPEPHSPG GIRLPNGKLK CDVCGMVCIG PNVLMVHKRS HTGERPFHCN QCGASFTQKG NLLRHIKLHS GEKPFKCPFC NYACRRRDAL TGHLRTHSVS SPTVGKPYKC NYCGRSYKQQ STLEEHKERC HNYLQSLSTE AQALAGQPGD EIRDLEMVPD SMLHSSSERP TFIDRLANSL TKRKRSTPQK FVGEKQMRFS LSDLPYDVNS GGYEKDVELV AHHSLEPGFG SSLAFVGAEH LRPLRLPPTN CISELTPVIS SVYTQMQPLP GRLELPGSRE AGEGPEDLAD GGPLLYRPRG PLTDPGASPS NGCQDSTDTE SNHEDRVAGV VSLPQGPPPQ PPPTIVVGRH SPAYAKEDPK PQEGLLRGTP GPSKEVLRVV GESGEPVKAF KCEHCRILFL DHVMFTIHMG CHGFRDPFEC NICGYHSQDR YEFSSHIVRG EHKVG //